Supporting Information -Bajrami et al Synthetic lethality of PARP and NAMPT inhibition in triple negative breast cancer cells
Mean tumour volumes and SEMs of tumour volumes for each cohort described in Figure 6 . Raw Cell Titre Glo luciferase readings from the HTS were processed as described in (Lord et al, 2008) . In brief, Cell Titre Go readings were first log 2 transformed and then centered according to the plate log 2 transformed median. The effect on PARP inhibitor sensitivity caused by each siRNA was calculated according to the following equation: Drug Effect (DE) of siRNA for gene X = (median centered data from olaparib-treated wells for gene X) -(median centered data from DMSO-treated wells for gene X). Calculation of the Median Absolute Deviation (MAD) was used to estimate the variance of the DE data. Standardised Z scores for DE were calculated using DE values, the median DE from the entire library and the MAD as variables. A similar analysis was conducted to estimate the effect of each siRNA upon cell viability in the absence of olaparib and siRNAs that caused significant cell inhibition alone (Z<-3) were excluded from the final analysis. In total we used data from three biological replicate screens in the final analysis. (A) Dynamic range of the screen/tranfection efficiency was assessed by comparing the median viability effects (and variance) of siRNAs targeting essential genes. Z prime (Boutros et al, 2006) plots generated by Cell HTS2 (Boutros et al, 2006) indicate a suitable dynamic range between lethal siRNAs targeting either PLK1 or UBB and control, non-targeting siRNAs and thus a high-efficiency transfection. (B) Schematic of high-throughput siRNA screen targeting 44 PARP and NAD metabolism proteins. The genes targeted in the siRNA library were curated from literature descriptions of proteins having well-established or casual links to NAD metabolism and these are listed in Supporting Table 1 . CAL51 cells were reverse transfected in a 96 well-plate format with Dharmacon siGENOME SMARTPools siRNAs. Forty-eight hours after transfection, media either containing the clinical PARP1/2 inhibitor olaparib (1 µM final concentration) or the drug vehicle, DMSO, was added to replica plates. After five days continuous culture in the presence of olaparib, cell viability was estimated using Cell-Titre Glo (Promega). Screen data was processed as described in the Materials and Methods. (C) Performance of biological replicas analysed using Spearman's coefficient R= 0.45-0.97. Supporting Table S6 . . CAL51 cells were exposed to FK866 for 48 hours and assessed as in the materials and methods. Table 2 Supporting Table 6 Cell line FK866 concentration ( 
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